Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
102.82
+1.23 (1.21%)
Feb 9, 2026, 4:00 PM EST - Market closed

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14
Total Diagnostics Revenue (Pre-Q3 2022)
1.42B1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth
5.05%-6.98%
Revenue (Other)
1.43B1.40B
Revenue (Total)
2.86B2.76B
Revenue (Total) Growth
3.67%0.16%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022)
1.43B1.40B
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) Growth
2.32%8.22%
Total Diagnostics Revenue (Pre-Q3 2022)
1.42B1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth
5.05%-6.98%
Revenue (Total)
2.86B2.76B
Revenue (Total) Growth
3.67%0.16%

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14
Total Diagnostics Revenue (Pre-Q3 2022)
1.42B1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth
5.05%-6.98%
Total Product Revenue
-2.34B
Total Product Revenue Growth
--3.21%
Total Service Revenue
-416.82M
Total Service Revenue Growth
-24.54%
Revenue (Total)
2.86B2.76B
Revenue (Total) Growth
3.67%0.16%

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14
Discovery & Analytical Solutions Operating Income (Post-Q2 2022)
458.26M467.28M
Discovery & Analytical Solutions Operating Income (Post-Q2 2022) Growth
-1.93%-4.51%
Diagnostics Operating Income (Pre-Q3 2022)
344.17M353.94M
Diagnostics Operating Income (Pre-Q3 2022) Growth
-2.76%10.29%
Operating Income (Total)
356.64M346.74M
Operating Income (Total) Growth
2.85%15.36%

EBIT 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14
Diagnostics Operating Income (Pre-Q3 2022)
344.17M353.94M
Diagnostics Operating Income (Pre-Q3 2022) Growth
-2.76%10.29%
Operating Income (Total)
356.64M346.74M
Operating Income (Total) Growth
2.85%15.36%
Updated Feb 2, 2026. Data Source: Fiscal.ai.